U.S. flag

An official website of the United States government

NC_000002.11:g.(?_72359356)_(74779761_?)del AND MOGS-congenital disorder of glycosylation

Germline classification:
no classifications from unflagged records (1 submission)
Review status:
no classifications from unflagged records
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003109485.5

Allele description

NC_000002.11:g.(?_72359356)_(74779761_?)del

Genes:
Variant type:
Deletion
Cytogenetic location:
2p13.2-13.1
Genomic location:
Chr2: 72359356 - 74779761 (on Assembly GRCh37)
Preferred name:
NC_000002.11:g.(?_72359356)_(74779761_?)del
HGVS:
NC_000002.11:g.(?_72359356)_(74779761_?)del

Condition(s)

Name:
MOGS-congenital disorder of glycosylation
Synonyms:
CDG IIb; GLUCOSIDASE I DEFICIENCY; Congenital disorder of glycosylation type 2B; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0011629; MedGen: C1853736; Orphanet: 79330; OMIM: 606056

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

No clinical assertions found. See "Flagged submissions" below.

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

Sadat MA, Moir S, Chun TW, Lusso P, Kaplan G, Wolfe L, Memoli MJ, He M, Vega H, Kim LJY, Huang Y, Hussein N, Nievas E, Mitchell R, Garofalo M, Louie A, Ireland DC, Grunes C, Cimbro R, Patel V, Holzapfel G, Salahuddin D, et al.

N Engl J Med. 2014 Apr 24;370(17):1615-1625. doi: 10.1056/NEJMoa1302846. Epub 2014 Apr 9.

PubMed [citation]
PMID:
24716661
PMCID:
PMC4066413

Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation.

Kane MS, Davids M, Adams C, Wolfe LA, Cheung HW, Gropman A, Huang Y; NISC Comparative Sequencing Program., Ng BG, Freeze HH, Adams DR, Gahl WA, Boerkoel CF.

Am J Hum Genet. 2016 Feb 4;98(2):339-46. doi: 10.1016/j.ajhg.2015.12.007. Epub 2016 Jan 21.

PubMed [citation]
PMID:
26805780
PMCID:
PMC4746335
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV003791461.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

A gross deletion of the genomic region encompassing the full coding sequence of the MOGS gene has been identified. Loss-of-function variants in MOGS are known to be pathogenic (PMID: 24716661, 26805780). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with MOGS-related conditions. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Flagged submissions

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003791461Invitae
flagged submission
Reason: This record appears to be redundant with a more recent record from the same submitter.
Notes: SCV003791461 appears to be redundant with SCV003792832.

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 29, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Last Updated: Feb 14, 2024